APA (7th ed.) Citation

CW, H., EE, C., E, S., K, Y., H, G., C, P., . . . K, S. (2023). Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. Therapeutic advances in gastroenterology, 16, 17562848231168714. https://doi.org/10.1177/17562848231168714

Chicago Style (17th ed.) Citation

CW, Howden, Cook EE, Swallow E, Yang K, Guo H, Pelletier C, Jacob R, and Sugano K. "Real-world Outcomes Associated with Vonoprazan-based Versus Proton Pump Inhibitor-based Therapy for Helicobacter Pylori Infection in Japan." Therapeutic Advances in Gastroenterology 16 (2023): 17562848231168714. https://doi.org/10.1177/17562848231168714.

MLA (9th ed.) Citation

CW, Howden, et al. "Real-world Outcomes Associated with Vonoprazan-based Versus Proton Pump Inhibitor-based Therapy for Helicobacter Pylori Infection in Japan." Therapeutic Advances in Gastroenterology, vol. 16, 2023, p. 17562848231168714, https://doi.org/10.1177/17562848231168714.